These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| | | |
Page
|
| |||
| | | | | 1 | | | |
| | | | | 6 | | | |
| | | | | 8 | | | |
| | | | | 18 | | | |
| | | | | 23 | | | |
| | | | | 24 | | | |
| | | |
|
| | ||
| | | | | B-1 | | | |
| | | | | By the Order of the Board of Directors: | | |||
| | | | | /s/ Jeffrey Holman | | |||
| | | | |
Jeffrey Holman,
Chairman of the Board and Chief Executive Officer |
| |||
|
Proposals
|
| |
Vote Required
|
| |
Broker
Discretionary Vote Allowed |
| |
Effect of
Abstentions on the Proposal |
|
|
(1)
To approve an amendment to the Certificate of Incorporation to effect a reverse stock split of our issued and outstanding shares of Common Stock at a ratio and effective upon a date to be determined by Board and effect a corresponding change in the par value of shares of our Common Stock from $0.001 to $0.0001
|
| |
Majority of the outstanding voting shares
|
| |
Yes
|
| |
Vote against
|
|
|
(2)
To approve an amendment to the Certificate of Incorporation, to increase the number of authorized shares of the Company’s Common Stock from 500,000,000 shares, par value $0.001, to 5,000,000,000, par value $0.0001
|
| |
Majority of the outstanding voting shares
|
| |
Yes
|
| |
Vote against
|
|
|
(3)
To authorize an adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes in favor of the Reverse Stock Split and the Authorized Share Increase
|
| |
Majority of the votes cast
|
| |
Yes
|
| |
No effect
|
|
|
Name of Beneficial Owner
|
| |
Number of
Common Share Equivalents Beneficially Owned (1) |
| |
Percentage of
Common Share Equivalents Beneficially Owned |
| ||||||
| Named Executive Officers and Directors: | | | | ||||||||||
|
Jeffrey Holman
(2)
|
| | | | 232,221 | | | | | | 2.23 % | | |
|
Kevin Frija
(3)
|
| | | | 10,875 | | | | | | * | | |
|
Harlan Press
(4)
|
| | | | 27,399 | | | | | | * | | |
|
Christopher Santi
(5)
|
| | | | 23,000 | | | | | | * | | |
|
Gregory Brauser
(6)
|
| | | | 207,719 | | | | | | 2.00 % | | |
|
James Martin
(7)
|
| | | | 41,543 | | | | | | * | | |
|
Gina Hicks
(8)
|
| | | | 0 | | | | | | 0 % | | |
|
William Conway III
(9)
|
| | | | 0 | | | | | | 0 % | | |
|
Daniel MacLachlan
(10)
|
| | | | 0 | | | | | | 0 % | | |
|
Nikhil Raman
(11)
|
| | | | 0 | | | | | | 0 % | | |
|
All Executive Officers and
Directors as a Group
(10 Persons)
(12)
|
| | | | 542,757 | | | | | | 5.22 % | | |
| Other Five Percent Stockholder: | | | | ||||||||||
|
Sabby Healthcare Master Fund, Ltd
|
| | | | 893,114 | | | | | | 8.61 % | | |
| | | |
Common Stock and
Equivalents Outstanding Prior to Reverse Stock Split |
| |
Common Stock and Equivalents Outstanding
Assuming Certain Reverse Stock Split Ratios |
| ||||||||||||||||||||||||
| | | |
Shares
|
| |
Percent of
Total |
| |
1-for-10
|
| |
1-for-40
|
| |
1-for-70
|
| |||||||||||||||
|
Common Stock outstanding
|
| | | | 10,373,935 | | | | | | 3.12 % | | | | | | 1,037,394 | | | | | | 259,348 | | | | | | 148,199 | | |
|
Common Stock subject to Vesting
|
| | | | 25,733 | | | | | | 0.01 % | | | | | | 2,573 | | | | | | 643 | | | | | | 367 | | |
|
Common Stock underlying warrants
(1)
|
| | | | 312,425,792 | | | | | | 94.03 % | | | | | | 31,242,580 | | | | | | 7,810,645 | | | | | | 4,463,226 | | |
|
Common Stock underlying options
|
| | | | 39,206 | | | | | | 0.01 % | | | | | | 3,921 | | | | | | 980 | | | | | | 560 | | |
|
Common Stock reserved for conversion of Series A Convertible Preferred Stock
|
| | | | 9,404,143 | | | | | | 2.83 % | | | | | | 940,414 | | | | | | 235,104 | | | | | | 134,345 | | |
|
Total Common Stock and equivalents
|
| | | | | | | | | | 100 % | | | | | | | | | | | | | | | | | | | | |
|
Common Stock available for future issuance
(2)
|
| | | | 167,731,191 | | | | | | | | | | | | 4,516,773,118 | | | | | | 4,504,193,280 | | | | | | 4,502,396,160 | | |
| | ANNEX A | | | Form of Proxy Card | |
| | ANNEX B | | | Certificate of Amendment to Certificate of Incorporation regarding the Reverse Stock Split and the Authorized Share Increase | |
| | | | | By Order of the Board of Directors, | | |||
| | | | | /s/ Jeffrey Holman | | |||
| | | | |
Jeffrey Holman
Chairman and Chief Executive Officer |
| |||
| | | The Board of Directors recommends you vote FOR Proposals 1, 2 and 3. | | | ||||||||||||||||
| | | | | | | | | | |
FOR
|
| | |
AGAINST
|
| | |
ABSTAIN
|
| |
| | | (1) | | | | To approve an amendment to the Company’s Seventh Amended and Restated Certificate of Incorporation, as amended (the “ Certificate of Incorporation ”), to effect a reverse stock split of our issued and outstanding shares of Common Stock at a ratio and effective upon a date to be determined by the Company’s board of directors and effect a corresponding change in the par value of shares of our Common Stock from $0.001 to $0.0001 (the “ Reverse Stock Split ”). | | | |
☐
|
| | |
☐
|
| | |
☐
|
| |
| | | (2) | | | | To approve an amendment to the Company’s Certificate of Incorporation, as amended (the “ Certificate of Incorporation ”), to increase the number of authorized shares of the Company’s Common Stock from 500,000,000 shares, par value $0.001, to 5,000,000,000, par value $0.0001 (the “ Authorized Share Increase ”). | | | |
☐
|
| | |
☐
|
| | |
☐
|
| |
| | | (3) | | | | To authorize an adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes in favor of the Reverse Stock Split and/or the Authorized Share Increase (the “ Adjournment Proposal ”). | | | |
☐
|
| | |
☐
|
| | |
☐
|
| |
| | |
NOTE:
In their discretion, the proxies are authorized to vote upon such other business as may properly come before the meeting or any adjournment thereof.
|
| | | | | | | | | | | | | | ||||
| | | | | VAPOR CORP. | | |||
| | | | | By: | | |
/s/ Jeffrey Holman
|
|
| | | | | | | |
Jeffrey Holman,
Chief Executive Officer |
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|